Thermo Fisher Scientific Introduces Software, Instruments, and Consumables - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Thermo Fisher Scientific Introduces Software, Instruments, and Consumables


Thermo Fisher Scientific launched new software, instruments, consumables, and services for analytical applications at Pittcon 2013.

Thermo Scientific Chromeleon ver. 7.2 chromatography data systems software, supports Thermo Scientific mass spectrometers and allows instruments to be integrated on enterprise-wide networks.

The Thermo Scientific Nicolet iS50 spectrometer can be upgraded from a FT-IR system to multi-range device capable of ATR, Raman, and NIR analysis without manually changing components.

The Thermo Scientific Dionex UltiMate 3000 Biocompatible Rapid Separation (BioRS) system, combines ultra-high performance liquid chromatography (UHPLC) with a corrosion-resistant flow path that can withstand high salt or extreme pH conditions.

The Thermo Scientific Dionex GlycanPac AXH-1 HPLC column allows for better analysis of glycans.

The iCAP 7000 family of inductively coupled plasma-optical emission spectrometers (ICP-OES) feature a high-resolution charged injection device (CID) imager.

The Thermo Scientific PicoSpin-45 spectrometer is a miniature NMR spectrometer designed for applied analysis in laboratories of any size.

Unity Lab SmartCapture Asset Utilization Monitoring provides automated support, service and maintenance, regardless of the instrument manufacturer.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here